Arkolith/Insider Trading/KTTA/Form 4

Steinman Lawrence

DirectorPasithea Therapeutics Corp. (KTTA) · full profile →Form 4 · filed Dec 1, 2025
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 28, 2025Buy(P)133K$0.75$100K200K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-116309) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML